ABBV vs. WMT: AbbVie vs. Walmart Stock Comparison

November 11, 2026

How do AbbVie (ABBV) and Walmart (WMT) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Walmart (WMT) belongs to Consumer Staples (Consumer Staples Distribution & Retail) — their GICS classifications point to very different parts of the market.

Company profile comparison for AbbVie (ABBV) and Walmart (WMT)
Profile Item	ABBV	WMT
Name	AbbVie Inc.	Walmart Inc.
Country/Region	United States	United States
GICS Sector	Health Care	Consumer Staples
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Consumer Staples Distribution & Retail
GICS Industry	Biotechnology	Consumer Staples Distribution & Retail
GICS Sub-Industry	Biotechnology	Consumer Staples Merchandise Retail
Market Capitalization	514.92 billion USD	998.90 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	January 2, 2013	August 25, 1972
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABBV

WMT

GSPC

AbbVie (ABBV) vs. Walmart (WMT), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for AbbVie (ABBV) and Walmart (WMT). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for AbbVie (ABBV) and Walmart (WMT). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
Total Return (1Y)	37.33%	23.19%
Total Return (3Y, Annualized)	32.74%	33.27%
Total Return (5Y, Annualized)	24.73%	21.72%

Risk Profile

Drawdown History

ABBV

WMT

GSPC

AbbVie (ABBV) vs. Walmart (WMT), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for AbbVie (ABBV) and Walmart (WMT). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
Volatility (1Y, Annualized)	25.65%	26.96%
Beta (5Y)	0.21	0.52
Max Drawdown (5Y)	-21.92%	-25.74%
Avg. Volume (3M)	4.76M	23.66M

Risk-Adjusted Performance

Risk-Return Positioning

ABBV and WMT are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
Sharpe Ratio (1Y)	1.29	0.70
Sortino Ratio (1Y)	2.02	1.00

Profitability

ROE (TTM)

Capital efficiency shows on one side only: Walmart (WMT) earns 22.31% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 109.18%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%
ABBV: --

WMT

Consumer Staples Distribution & Retail industry group

22.31%

Max: 33.48%
WMT: 22.31%
Q3: 22.31%
Median: 15.57%
Q1: 7.66%
Min: -2.27%

AbbVie (ABBV) vs. Walmart (WMT): ABBV does not report ROE, so it has no value marker; WMT is benchmarked against the Consumer Staples Distribution & Retail industry group.

Net Margin (TTM)

AbbVie (ABBV) at 15.67% retains a top-quartile share of revenue as profit, ahead of Walmart (WMT) at 3.00%, which keeps about the industry-typical share.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max: 18.05%
ABBV: 15.67%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

WMT

Consumer Staples Distribution & Retail industry group

3.00%

Max: 5.45%
Q3: 3.42%
WMT: 3.00%
Median: 2.44%
Q1: 1.86%
Min: -0.06%

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

Operating Margin (TTM)

AbbVie (ABBV) at 39.59% operates in the top operating margin quartile, ahead of Walmart (WMT) at 3.45%, which runs around its industry’s norm.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max: 83.12%
ABBV: 39.59%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

WMT

Consumer Staples Distribution & Retail industry group

3.45%

Max: 6.81%
Q3: 5.49%
Median: 3.84%
WMT: 3.45%
Q1: 2.00%
Min: 0.97%

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
ROE (TTM)	--	22.31%
ROA (TTM)	10.74%	6.41%
Net Margin (TTM)	15.67%	3.00%
Operating Margin (TTM)	39.59%	3.45%
Gross Margin (TTM)	73.72%	24.84%

Growth

Revenue Growth

Both AbbVie (ABBV) at 8.57% and Walmart (WMT) at 4.73% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both AbbVie (ABBV) at -0.84% and Walmart (WMT) at 13.28% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
Revenue Growth (YoY)	8.57%	4.73%
Revenue Growth (3Y CAGR)	1.75%	5.27%
EPS Growth (YoY)	-0.84%	13.28%
EPS Growth (3Y CAGR)	-29.03%	24.25%

Financial Strength

Current Ratio (MRQ)

Both AbbVie (ABBV) at 0.87 and Walmart (WMT) at 0.77 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
ABBV: 0.87
Min: 0.10

WMT

Consumer Staples Distribution & Retail industry group

0.77

Max: 2.04
Q3: 1.45
Median: 1.17
Q1: 1.00
WMT: 0.77
Min: 0.69

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: Walmart (WMT) carries debt-to-equity ratio of 0.72 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

Max: 1.42
Q3: 0.65
Median: 0.15
Q1: 0.02
Min: 0.00
ABBV: --

WMT

Consumer Staples Distribution & Retail industry group

0.72

Max: 2.59
Q3: 1.83
Median: 1.24
WMT: 0.72
Q1: 0.63
Min: 0.01

AbbVie (ABBV) vs. Walmart (WMT): ABBV does not report debt-to-equity ratio, so it has no value marker; WMT is benchmarked against the Consumer Staples Distribution & Retail industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
Current Ratio (MRQ)	0.87	0.77
Debt / Equity (MRQ)	--	0.72
Net Debt / EBITDA	2.21	1.44

Dividends

Dividend Yield (TTM)

Walmart (WMT) at 0.76% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV: 2.40%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

WMT

Consumer Staples Distribution & Retail industry group

0.76%

Max: 2.90%
Q3: 1.72%
WMT: 0.76%
Median: 0.43%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Walmart (WMT) reports 34.96%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV: 117.35%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

WMT

Consumer Staples Distribution & Retail industry group

34.96%

Max: 57.98%
WMT: 34.96%
Q3: 30.05%
Median: 11.72%
Q1: 0.00%
Min: 0.00%

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
Dividend Yield (TTM)	2.40%	0.76%
Dividend Payout Ratio (TTM)	117.35%	34.96%

Valuation

P/E Ratio (TTM)

Both AbbVie (ABBV) at 50.05 and Walmart (WMT) at 45.48 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max: 85.34
ABBV: 50.05
Q3: 43.46
Median: 26.69
Q1: 13.30
Min: 0.07

WMT

Consumer Staples Distribution & Retail industry group

45.48

Max: 50.75
WMT: 45.48
Q3: 33.64
Median: 22.19
Q1: 16.09
Min: 9.28

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while Walmart (WMT) at 1.36 sits in the pricier quartile — WMT costs more per dollar of sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max: 58.18
Q3: 25.77
ABBV: 7.80
Median: 7.30
Q1: 3.01
Min: 0.01

WMT

Consumer Staples Distribution & Retail industry group

1.36

Max: 1.54
WMT: 1.36
Q3: 0.81
Median: 0.47
Q1: 0.26
Min: 0.02

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Walmart (WMT) reports 10.15, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max: 13.53
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59
ABBV: -112.34

WMT

Consumer Staples Distribution & Retail industry group

10.15

WMT: 10.15
Max: 10.15
Q3: 6.27
Median: 3.70
Q1: 1.85
Min: 0.93

AbbVie (ABBV) vs. Walmart (WMT): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Consumer Staples Distribution & Retail industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and Walmart (WMT)
Metric	ABBV	WMT
P/E Ratio (TTM)	50.05	45.48
P/S Ratio (TTM)	7.80	1.36
P/B Ratio (MRQ)	-112.34	10.15
Free Cash Flow Yield (TTM)	3.44%	0.71%